FDA Could Make Generics Liable Amid Push To Undo Mensing

Law360, New York (March 28, 2012, 8:04 PM EDT) -- Recent public outcry over the U.S. Supreme Court's decision in Pliva v. Mensing to shield generic-drug makers from product liability suits could push the U.S. Food and Drug Administration to enact regulations that would make them liable for failure-to-warn claims, experts say.

On Monday, Sen. Patrick Leahy, D-Vt., promised legislation that would counteract Mensing, joining public interest groups in criticizing the June ruling that federal law preempts state failure-to-warn claims against generics companies as one that creates a "two-track system" that punishes consumers who take generic drugs.

While Leahy's bill...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.